News und Analysen

Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the preliminary results of its substantial issuer bid (the “Offer”), which expired at 5:00 p.m. (Toronto Time) on

Glory, a global leader in cash technology solutions, is pleased to announce the appointment of Joseph Gnorski as President of Glory Americas. In his new role, Gnorski will oversee the Americas

Glory, a global leader in cash technology solutions, is pleased to announce the appointment of Joseph Gnorski as President of Glory Americas. In his new role, Gnorski will oversee the Americas

Glory, a global leader in cash technology solutions, is pleased to announce the appointment of Joseph Gnorski as President of Glory Americas. In his new role, Gnorski will oversee the Americas

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological

CI Global Asset Management (“CI GAM”) announces the following estimated reinvested distributions (the “Estimated Reinvested Distributions”) in respect of the upcoming mergers of the ETFs and ETF

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and

Regulatory News:

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2023 and provided an update on key proprietary clinical

CI Global Asset Management (“CI GAM”) announces it has received securityholder approval for a series of enhancements to its product lineup, including the merger of 11 mutual funds into other mutual

Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today that, in connection with its previously announced consent and proxy solicitation (“Consent and Proxy Solicitation

CI Global Asset Management (“CI GAM”) announces that it has received the required securityholder approval of several proposed changes to its product lineup, including the merger of eight mutual

CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $465.9 billion as at February 29, 2024, consisting of asset management assets of $128.0 billion, Canadian wealth

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

Mannatech, Incorporated (NASDAQ: MTEX) reported that Alfredo (Al) Bala, announced his retirement as the company’s CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending March 31, 2024 in respect of the CI ETFs. In all cases, the distribution

Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control, and water treatment in utility and industrial

Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control and water treatment in utility and industrial

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced